
Not your average farmer. Winners always win. My music @TheUrbanFarmer(all platforms) most songs https://teapaw.org/t.co/wuKdH0WLVV dm 4 discord inv
Based City, USA.
Joined January 2022
- Tweets3.3K
- Following95
- Followers1.3K
- Likes10.4K
Today, at the @Stifel 2026 Healthcare Conference, Ocugen CEO @drsmusunuri highlighted our novel modifier #genetherapy platform and three Phase 3 investigational assets in NYC. #Biotech
Watch the replay: bit.ly/4zdvc2f
$OCGN
TheUrbanFarmer retweeted
$OCGN
Disruptive. What a fitting word. Brilliant conference @drsmusunuri . Congratulations to you and team Ocugen!
Today, at the @Stifel 2026 Healthcare Conference, Ocugen CEO @drsmusunuri highlighted our novel modifier #genetherapy platform and three Phase 3 investigational assets in NYC. #Biotech
Watch the replay: bit.ly/4zdvc2f
$OCGN
TheUrbanFarmer retweeted
New Research Report: Ocugen (OCGN) – 3Q26 Reported With Expected Progress In All Three Trials
$OCGN #Ocugen #Investing #EquityResearch
channelchek.com/news-channel…
TheUrbanFarmer retweeted
$OCGN #OCUGEN @Ocugen @drsmusunuri .... love seeing patient after patien seeing the improvements.
Thank you @Ocugen team!!!
$OCGN The drugs are everything, and nearly every single piece of evidence we see suggests the trials are going damn well. Hearing patient after patient describe their improvements, and now over a year after treatment hearing them say they’re still seeing improvements, is exactly what an investor wants to see with phase 3 results just months away.
If this is the norm for people in the trial/EAP, the results will be beyond stellar and well beyond what’s needed to meet the primary endpoint. We’re going from having money riding on a speculative biotech to owning a piece of the next big pharma. 🍻
Ocugen is taking part in two key industry events this November!
CEO @drsmusunuri will participate in the Stifel 2026 Healthcare Conference and Cell & Gene Leaders Live 2026. Read more: bit.ly/4ss67Pm
#HealthcareInnovation #GeneTherapy $OCGN
Today, FDA kicked off its Rare Disease Framework Initiative with a public meeting, co-hosted by @ReaganUdall. Thanks to all who joined for your input, candor & vision. With only 5% of rare diseases having an approved treatment, the status quo isn't enough — we must do more.
FDA Acting Commissioner @FDA_KyleD shared with the attendees that the “urgency of the need has not changed, but now we — the agency, drug developers, researchers, and patients — are ready to meet that need together.”
TheUrbanFarmer retweeted
Cell and gene therapies can change what’s possible for patients living with rare and severe diseases. Cost shouldn’t put that possibility out of reach.
CMS is expanding our Cell and Gene Therapy Access Model to help more Medicaid patients access these life-changing treatments. Learn more about the CGT 2.0 Model: go.cms.gov/CGT
At Cleveland Clinic today, CMS Innovation Center Director Abe Sutton, @DrOzCMS, and @FDA_KyleD announced that CMS will invite manufacturers of other cell and gene therapies to apply to the CGT Access Model. Learn more: go.cms.gov/CGT
TheUrbanFarmer retweeted
TheUrbanFarmer retweeted
Replying to @drsmusunuri
@drsmusunuri @Ocugen This video is amazing hearing his real world improvements, not just the usual numbers on an eye test. I know you're looking at a PGIC questionnaire as an exploratory endpoint but in my opinion it should hold significant weight 💪🫶 youtu.be/IlAu5uC7MRY?is=BC-e…
TheUrbanFarmer retweeted
NEW UPDATE FROM JP 🚨
7 Months after #OCU400 his Vision is improving so much ✅
#Ocugen have the best Therapy for #retinitispigmentosa that will be soon be at Clinics 🚀🚀🚀
@MoreFlax @NattaCop @BRexNew
youtu.be/IlAu5uC7MRY?is=N9DX…
An important milestone at #AAO2026! During the @aao_ophth Annual Meeting, Raj K. Maturi, MD, presented 12-month safety and efficacy results from our Phase 2 ArMaDa trial evaluating #OCU410 for #geographicatrophy, supporting its continued advancement in Phase 3. #GeneTherapy $OCGN
Read more from @ophth_advisor: bit.ly/4e9Qh67
TheUrbanFarmer retweeted
Excited to welcome Jolanda Crombach to the Ocugen team as General Manager of our European affiliate. Looking forward to working together as we expand our presence in Europe and advance our mission to bring transformative therapies to patients globally!
Jolanda Crombach, MSc PharmD, has been appointed General Manager of our newly established European affiliate, headquartered in Amsterdam, to support our three Phase 3 novel modifier #GeneTherapy programs and potential #commercialization. #Biotech $OCGN
Read more: bit.ly/4y1ImyI
TheUrbanFarmer retweeted
Another exciting milestone for OCU400 as we work to bring this innovative therapy to patients globally!
Hear from CEO @drsmusunuri on how the LARTA Board in the Bahamas is enabling access to #OCU400 for #retinitispigmentosa through an Expanded Access Program with #commercialpricing and its potential to help patients worldwide. @MOHW242 #Genetherapy $OCGN 🔗 bit.ly/4xNFDZR
Hear from CEO @drsmusunuri on how the LARTA Board in the Bahamas is enabling access to #OCU400 for #retinitispigmentosa through an Expanded Access Program with #commercialpricing and its potential to help patients worldwide. @MOHW242 #Genetherapy $OCGN 🔗 bit.ly/4xNFDZR
TheUrbanFarmer retweeted
#OCU400, our #genetherapy for #retinitispigmentosa, received provisional approval and priority designation from the LARTA Board in the Bahamas, a significant step as we advance our mission globally.
@MOHW242 $OCGN #CommercialPricing 🔗bit.ly/4xNFDZR
































